SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-069622
Filing Date
2024-08-15
Accepted
2024-08-15 16:05:33
Documents
14
Period of Report
2024-08-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211542-8k_ostherap.htm   iXBRL 8-K 27372
2 PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON AUGUST 15, 2024 ea021154201ex99-1_ostherap.htm EX-99.1 21920
  Complete submission text file 0001213900-24-069622.txt   230914

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ostx-20240815.xsd EX-101.SCH 3024
4 XBRL LABEL FILE ostx-20240815_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ostx-20240815_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0211542-8k_ostherap_htm.xml XML 3807
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 241212405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)